Add to ORKG131I-metaiodobenzylguanidine (MIBG) has been used as a thera-peutic agent for pheochromocytoma. Tumor localization and pre-cise staging are essential for therapy with high-dose 131I-MIBG. The sites and extent of 123I-MIBG uptake are usually estimated to predict the effectiveness of therapy before administration. However, conventional scintigraphic images provide insufficient anatomic information. Therefore, we tried to manually superim-pose 123I-MIBG SPECT and CT images using free software
Pheochromocytomas are rare tumors arising from chromaffin cells of adrenal medullary or extra-adrena...
OBJECTIVE: To determine the diagnostic value of metaiodobenzylguanidine (MIBG) scintigraphy compared...
The development of the aralkylguanidine [131I]m-iodobenzylguanidine ([131I]MIBG) in the University o...
131I-metaiodobenzylguanidine (MIBG) has been used as a thera-peutic agent for pheochromocytoma. Tumo...
Preliminary clinical studies with 131I-meta-iodobenzylguanidine, a newly synthesized radiopharmaceut...
The results of 131I metaiodobenzylguanidine (MIBG) and Computed Tomography (CT) scans in a group of ...
The successful application of [131l]metaiodobenzylguanidine (MIBG) in diagnosis and therapy of pheoc...
The results of 131I metaiodobenzylguanidine (MIBG) and Computed Tomography (CT) scans in a group of ...
In a patient with the clinical diagnosis of pheochromocytoma, the localization of the tumor is essen...
BACKGROUND: Recommendations on the use of I-123 metaiodobenzylguanidine (MIBG) scintigraphy in local...
Abstract Background Pheochromocytomas are rare neuroendocrine tumors, with a malignancy frequency of...
textabstractSelecting the appropriate approach for resection and follow-up of pheochromoc...
Malignant pheochromocytomas, a group of tumors that include metastatic paragangliomas, often produce...
Selecting the appropriate approach for resection and follow-up of pheochromocytomas (PCCs) is highly...
Pheochromocytomas and paragangliomas (extra-adrenal pheochromocytomas) are relatively rare catechola...
Pheochromocytomas are rare tumors arising from chromaffin cells of adrenal medullary or extra-adrena...
OBJECTIVE: To determine the diagnostic value of metaiodobenzylguanidine (MIBG) scintigraphy compared...
The development of the aralkylguanidine [131I]m-iodobenzylguanidine ([131I]MIBG) in the University o...
131I-metaiodobenzylguanidine (MIBG) has been used as a thera-peutic agent for pheochromocytoma. Tumo...
Preliminary clinical studies with 131I-meta-iodobenzylguanidine, a newly synthesized radiopharmaceut...
The results of 131I metaiodobenzylguanidine (MIBG) and Computed Tomography (CT) scans in a group of ...
The successful application of [131l]metaiodobenzylguanidine (MIBG) in diagnosis and therapy of pheoc...
The results of 131I metaiodobenzylguanidine (MIBG) and Computed Tomography (CT) scans in a group of ...
In a patient with the clinical diagnosis of pheochromocytoma, the localization of the tumor is essen...
BACKGROUND: Recommendations on the use of I-123 metaiodobenzylguanidine (MIBG) scintigraphy in local...
Abstract Background Pheochromocytomas are rare neuroendocrine tumors, with a malignancy frequency of...
textabstractSelecting the appropriate approach for resection and follow-up of pheochromoc...
Malignant pheochromocytomas, a group of tumors that include metastatic paragangliomas, often produce...
Selecting the appropriate approach for resection and follow-up of pheochromocytomas (PCCs) is highly...
Pheochromocytomas and paragangliomas (extra-adrenal pheochromocytomas) are relatively rare catechola...
Pheochromocytomas are rare tumors arising from chromaffin cells of adrenal medullary or extra-adrena...
OBJECTIVE: To determine the diagnostic value of metaiodobenzylguanidine (MIBG) scintigraphy compared...
The development of the aralkylguanidine [131I]m-iodobenzylguanidine ([131I]MIBG) in the University o...